| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Year Ended December 31, |
| Financial statement caption | | 2024 | | 2023 | | 2022 | |
| Non-Designated Derivative Instruments | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Unrealized (gains) losses | Unrealized (gain) loss on derivative instruments, net | | $ | 40 | | | $ | (15) | | | $ | (343) | | |
| Designated Derivative Instruments | | | | | | | | |
| Realized (gains) losses | Interest and debt (income) expense | | $ | (50,795) | | | $ | (47,648) | | | $ | 260 | | |
| Unrealized (gains) losses | Comprehensive (income) loss | | $ | (55,913) | | | $ | (20,148) | | | $ | (168,156) | | |
| | | | | | | | |
| | | | | | | | |
